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Introduction {#sec1}
============

Maintaining constant body temperature in changing temperature environments is essential for survival of homeothermic vertebrates. Upon exposure to low ambient temperatures, mammals increase their oxidative metabolism for the production of heat. The major site for cold-induced non-shivering thermogenesis (NST) is brown adipose tissue (BAT), which contains the unique uncoupling protein-1 (UCP-1). UCP-1 resides within the inner mitochondrial membrane of brown adipocytes, where it dissipates the proton gradient generated by the electron transport chain ([@bib8], [@bib13]). The futile cycling of protons drives the oxidation of high amounts of energy substrates and produces heat. Based on the potential relevance of BAT function for energy expenditure in humans ([@bib10], [@bib48], [@bib30], [@bib49]), interest in stimulating BAT thermogenesis as a potential treatment strategy for metabolic disorders has been renewed ([@bib4], [@bib9], [@bib20], [@bib38], [@bib44]).

Cold sensation is transmitted to BAT primarily via the sympathetic nervous system. Catecholamines activate β~3~-adrenergic receptors, leading to an increase of cellular cAMP concentrations and activation of protein kinase A (PKA). Upon short-term cold exposure for several hours (acute cold), PKA increases the transcription of UCP-1 and peroxisome proliferator-activated receptor (PPAR)-γ co-activator 1α (PGC-1α). PGC-1α, in turn, co-activates PPAR-α, a crucial nuclear receptor orchestrating the transcriptional program for substrate oxidation and thermogenesis in BAT ([@bib33]). A sustained increase in sympathetic tone upon long-term cold exposure for several weeks (cold acclimation) additionally induces the recruitment of new brown adipocytes, leading to tissue hyperplasia and hypertrophy ([@bib5], [@bib6], [@bib11]).

Cold-induced adrenergic signaling also induces the hydrolysis of intracellular triacylglycerol (TG) stores (lipolysis) via the activation of the major TG hydrolases adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) ([@bib55]). According to the current view, BAT lipolysis is essential for cold-induced NST because BAT-derived fatty acids (FAs) (1) activate UCP-1 and (2) act as primary fuel substrate ([@bib7]). Several key findings supported this conclusion. (1) Global or adipocyte-specific ATGL knockout (AKO and AAKO, respectively) mice were unable to maintain body temperature upon acute cold and exhibited a lipolytic defect in BAT, leading to severe BAT hypertrophy due to TG accumulation ([@bib2], [@bib18]). (2) In differentiated brown adipocytes, pharmacological inhibition of ATGL activity attenuated cellular respiration, suggesting impaired UCP-1 activation and fuel supply ([@bib24]). (3) Enzymatically active ATGL is pivotal for the transcriptional activity of PPAR-α ([@bib19], [@bib29]). The findings that HSL and monoglyceride lipase (MGL) knockout mice are not cold sensitive ([@bib31], [@bib51]; own observations) suggested that especially ATGL function is crucial for cold-induced NST. However, the tissue-specific impact of ATGL in BAT, white adipose tissue (WAT), and cardiac muscle in cold-induced NST has not been directly addressed *in vivo*.

To define the physiological relevance of ATGL in individual tissues, we studied cold-induced NST in informative mutant mouse models ([Table 1](#tbl1){ref-type="table"}). We demonstrate that in the presence of exogenous substrate supply, either from the diet during feeding, or from WAT lipolysis during fasting, ATGL in BAT is not essential for cold-induced NST. Instead, our results emphasize the importance of a functional cardiovascular system for the maintenance of normal body temperature.Table 1Mouse Models Used in This StudySynonymGenotypeReferenceATGL Protein Expressed in:BATWATCMOther TissuesAKOATGL knockout[@bib18]--------iBAKOinducible BAT-specific ATGL knockoutthis study--+++AAKOadipocyte-specific ATGL knockout[@bib36]----++iHAKOinducible heart-specific ATGL knockout[@bib23]++--+AKO/cTgAKO overexpressing a cardiac-specific α-MHC-ATGL transgene[@bib39]----+--[^2]

Results {#sec2}
=======

Global ATGL Deficiency Causes Cold-Induced Hypothermia and BAT Hypertrophy, but Does Not Alter Mitochondrial Function in BAT {#sec2.1}
----------------------------------------------------------------------------------------------------------------------------

We first revisited AKO mice ([Table 1](#tbl1){ref-type="table"}; [@bib18]) to better understand how defective ATGL-mediated lipolysis affects key players in thermogenesis. ATGL deficiency decreased *in vitro* TG hydrolase activities in BAT lysates by 72% ([Figure 1](#fig1){ref-type="fig"}A). Addition of a specific small-molecule inhibitor for HSL (HSLi) further inhibited TG hydrolase activities more than 90% in AKO lysates compared to wild-type (WT). These data indicate that, as in WAT ([@bib40]), ATGL and HSL are the predominant TG hydrolases in BAT. Acute cold exposure at 5°C for 3--6 hr evoked severe hypothermia (body temperature \<31°C) in AKO mice ([Figure 1](#fig1){ref-type="fig"}B), but not in WT, confirming cold intolerance in AKO mice ([@bib18]). BAT of AKO mice was hypertrophic (∼6-fold increase in tissue weight) and resembled WAT morphology with large, unilocular adipocytes ([Figures 1](#fig1){ref-type="fig"}C and 1D). Consistent with the effect of ATGL knockdown in brown adipocytes ([@bib29]), global *Atgl* gene deletion resulted in lower BAT transcript levels for PPAR-α target genes ([Figure S1](#mmc1){ref-type="supplementary-material"}A) and classical BAT markers ([Figure 1](#fig1){ref-type="fig"}E). In contrast to decreased mRNA levels, UCP-1 protein abundance in isolated BAT mitochondria was similar in AKO and WT mice ([Figure 1](#fig1){ref-type="fig"}F).Figure 1Global ATGL Deficiency Causes Cold-Induced Hypothermia and BAT Hypertrophy, but Does Not Alter Mitochondrial Function in BAT(A) TG hydrolase activities of BAT infranatants in the absence or presence of HSL inhibitor (HSLi) from mice housed at 22°C--23°C (n = 3).(B) Body temperature in *ad libitum*-fed mice upon acute cold exposure at 5°C for 3--6 hr (n = 6).(C) BAT weight (n = 7).(D) Histology of BAT. Scale bar, 100 μm.(E) Relative mRNA expression of classical brown fat genes upon acute cold exposure (n = 6).(F) UCP-1 immunoblot of isolated BAT mitochondria upon acute cold exposure.(G) Total DNA content in whole BAT depots (n = 6).(H) DNA content in isolated brown adipocytes (adi) and stroma-vascular fraction (SVF; n = 3).(I) Total protein content in isolated mitochondria from whole BAT depots (n = 10).(J) Relative mtDNA content in BAT assessed by qPCR and calculated from copy numbers of the mtDNA-encoded MtCO1 gene and the nuclear DNA-encoded Ndufv1 gene (n = 6).(K) Representative transmission electron micrographs from BAT. Scale bar, 0.5 μm.(L) Oxygen consumption rates (OCRs) in BAT homogenates (hom) using pyruvate (pyr), glycerol-3-P (G3P) in the absence or presence of rotenone (R, G3P/R), and guanosine 5′-diphosphate (GDP). OCRs were calculated for whole BAT depots (n = 6--7).Analyses were performed in male mice, except for (H), which used female mice, aged 9--10 weeks. Data are presented as means ± SD. Statistical significance was evaluated by unpaired two-tailed Student's t test. ^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Total DNA content of whole BAT depots was higher in AKO than in WT mice ([Figure 1](#fig1){ref-type="fig"}G), suggesting hyperplasia in the absence of ATGL. BAT cell fractionation revealed an increased DNA content in both the brown adipocytes and the stroma-vascular fraction (SVF) of AKO mice ([Figure 1](#fig1){ref-type="fig"}H). Increased abundance of SVF cells resulted in increased mRNA levels of several immune cell markers (F4/80, CD11c, and IL-6) in BAT from AKO mice ([Figure S1](#mmc1){ref-type="supplementary-material"}B). These results suggested that global ATGL deficiency---in addition to BAT hypertrophy---also causes BAT hyperplasia.

In contrast to total DNA content in BAT, the total protein content from isolated mitochondria per whole BAT depot was not different between AKO and WT mice ([Figure 1](#fig1){ref-type="fig"}I), suggesting a decrease in the number of mitochondria in relation to total cell number. This finding was confirmed when we determined the ratio of mitochondrial DNA (mtDNA) to nuclear DNA (nDNA). The dosage of the mtDNA-encoded gene cytochrome oxidase-1 (MtCO1) was decreased by 55% in relation to the dosage of the nDNA-encoded gene Ndufv1 ([Figure 1](#fig1){ref-type="fig"}J).

ATGL deficiency leads to mitochondrial dysfunction in cardiomyocytes and β cells ([@bib19], [@bib45]). Thus, we assessed whether loss of ATGL also affects mitochondrial function in BAT as a potential cause for cold intolerance. Transmission electron microscopy provided no evidence for altered mitochondrial morphology displaying intact and dense mitochondrial cristae in both genotypes ([Figure 1](#fig1){ref-type="fig"}K). High-resolution respirometry of BAT homogenates demonstrated that oxygen consumption rates (OCRs) in BAT of AKO and WT mice were similar independently of whether respiration was fueled via complex-I, complex-II, or complex-I and complex-II substrates. OCRs were also comparable between genotypes in the presence of the UCP-1 inhibitor guanosine 5′-diphosphate (GDP). Thus, global ATGL deficiency causes pronounced morphological and cellular alterations in BAT, but does not overtly impair respiratory capacity *ex vivo*.

ATGL in BAT Is Not Essential for Thermogenesis during Acute Cold {#sec2.2}
----------------------------------------------------------------

To delineate the importance of ATGL in BAT for cold-induced NST, we generated mice lacking ATGL exclusively in BAT ([Table 1](#tbl1){ref-type="table"}) and assessed cold tolerance. Breeding of ATGL^flox/flox^ control ([@bib43]) with tamoxifen-inducible UCP-1-Cre^ER^ mice ([@bib34]) yielded inducible BAT-specific ATGL knockout (iBAKO) mice. Tamoxifen administration resulted in a substantial decrease of ATGL protein abundance (\>80%) in BAT homogenates of iBAKO mice ([Figure 2](#fig2){ref-type="fig"}A). Considering that brown adipocytes comprise less than 50% of the cell population in BAT ([@bib34]) and that other cell types such as endothelial and immune cells also express low levels of ATGL ([@bib35], [@bib37]), we assume that *Atgl* gene deletion in brown adipocytes reaches an efficiency of close to 100%. To investigate whether *Atgl* gene deletion in brown adipocytes affected lipolysis, we determined BAT glycerol release and BAT lysate TG hydrolase activities. *Ex vivo* glycerol release under basal conditions was 54% lower from iBAKO-BAT than from ATGL^flox/flox^-BAT ([Figure 2](#fig2){ref-type="fig"}B). A similar decrease was observed for isoproterenol (ISO)-stimulated glycerol release (−54%). *In vitro* TG hydrolase activities were 38% lower in BAT lysates from iBAKO than from ATGL^flox/flox^ control mice ([Figure 2](#fig2){ref-type="fig"}C). Addition of the specific small-molecule ATGL inhibitor Atglistatin (ATGLi) ([@bib28]) decreased TG hydrolase activities by 40% in BAT lysates from ATGL^flox/flox^ control, but not from iBAKO mice, arguing for efficient inactivation of ATGL in iBAKO mice. Similar to AKO mice, BAT mass from iBAKO mice was hypertrophic (∼4-fold increase in tissue weight) and contained large, unilocular adipocytes ([Figures 2](#fig2){ref-type="fig"}D and 2E). In contrast to BAT, epididymal WAT and inguinal WAT (epiWAT and ingWAT) showed normal ATGL protein expression, basal and ISO-stimulated glycerol release (from epiWAT), and tissue mass ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C), indicating that the UCP-1-Cre^ER^ promoter is specific for BAT. BAT-specific *Atgl* gene deletion did not alter body weight of iBAKO compared to ATGL^flox/flox^ control mice ([Figure S2](#mmc1){ref-type="supplementary-material"}D).Figure 2ATGL in BAT Is Not Essential for Thermogenesis during Acute Cold(A) ATGL immunoblot of BAT homogenates (n = 4; representative of at least two independent analyses).(B) *Ex vivo* lipolysis in BAT under basal and isoproterenol (ISO)-stimulated conditions (n = 4).(C) TG hydrolase activities in BAT infranatants in the absence or presence of ATGL inhibitor Atglistatin (ATGLi) from mice exposed to 5°C for 6 hr (n = 5).(D) BAT weight (n = 11) and tissue gross morphology (inset).(E) Histology of BAT. Scale bar, 100 μm.(F) Body temperature in *ad libitum*-fed mice during acute cold exposure at 5°C (n ≥ 5).(G) DNA content in brown adipocytes (adi) and stroma-vascular fraction (SVF; n = 3).(H) UCP-1 immunoblot of isolated BAT mitochondria upon acute cold exposure.(I) Oxygen consumption rates (OCRs) in BAT homogenates (hom) using pyruvate (pyr), glycerol-3-P (G3P) in the absence and presence of rotenone (G3P/R), and guanosine 5′-diphosphate (GDP). OCRs were calculated for whole BAT depots (n = 6).Analyses were performed in male mice, except for (G), which used female mice, aged 9--11 weeks and 4 weeks upon tamoxifen administration. Data are presented as means ± SD. Statistical significance was evaluated by unpaired two-tailed Student's t test or two-way ANOVA with Bonferroni post hoc tests. ^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001 versus ATGL^flox/flox^ control and ^§^p \< 0.05 versus basal. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

In stark contrast to AKO mice, iBAKO mice exhibited normal or even moderately increased body temperature during acute cold exposure at 5°C for 6 hr ([Figure 2](#fig2){ref-type="fig"}F). Unlike in AKO BAT, transcript levels of classical BAT marker genes as well as PPAR-α and its target genes were either not or only moderately decreased in BAT of iBAKO versus ATGL^flox/flox^ control mice ([Figures S2](#mmc1){ref-type="supplementary-material"}E and S2F compared with [Figures 1](#fig1){ref-type="fig"}E and [S1](#mmc1){ref-type="supplementary-material"}A). Nevertheless, we found a higher DNA content in both isolated brown adipocytes and SVF cells ([Figure 2](#fig2){ref-type="fig"}G) and increased transcript levels of immune cell markers like F4/80, CD11c, and IL-6 ([Figure S2](#mmc1){ref-type="supplementary-material"}G), indicating that ATGL deficiency in BAT causes brown adipocyte hyperplasia.

UCP-1 protein abundance and respiratory capacity in BAT homogenates in the presence of complex-I, complex-II, or complex-I and complex-II substrates were similar in both genotypes and independent of the absence or presence of the UCP-1 inhibitor GDP ([Figure 2](#fig2){ref-type="fig"}I). Together, these results show that the BAT-specific loss of ATGL changes BAT morphology, but does not impair respiratory function or cold-induced NST.

ATGL-Mediated Lipolysis in WAT Is Essential to Fuel Thermogenesis during Fasting {#sec2.3}
--------------------------------------------------------------------------------

iBAKO and AKO mice exhibit a different physiological response to cold stress. This suggests that other defects than impaired FA mobilization in brown adipocytes cause defective cold-induced NST in AKO mice. AKO mice develop hypothermia during cold, but also upon prolonged fasting at room temperature ([@bib18]). Food deprivation during cold amplifies the need for lipolysis to supply FAs for thermogenesis. To differentiate whether the pronounced susceptibility to hypothermia in AKO mice is due to (1) an autonomous defect in FA supply causing a local fuel deficiency within BAT or (2) impaired FA mobilization from WAT leading to a systemic fuel deficiency, we pursued two strategies. First, we fasted iBAKO mice either overnight for 12 hr at 22°C--23°C or for 6 hr at 5°C. iBAKO mice maintained their body temperature upon food deprivation in both conditions ([Figures S3](#mmc1){ref-type="supplementary-material"}A and [3](#fig3){ref-type="fig"}A). Upon food deprivation for 6 hr at 5°C, iBAKO mice retained normal blood glucose and plasma glycerol concentrations but exhibited higher plasma FA (+17%) and TG (+90%) levels than ATGL^flox/flox^ control mice ([Figure 3](#fig3){ref-type="fig"}B).Figure 3ATGL-Mediated Lipolysis in WAT Is Essential to Fuel Thermogenesis during Fasting(A and C) Body temperature in iBAKO (A) and AAKO (C) mice during fasting at 5°C at indicated time points.(B and D) Blood glucose, plasma FA, glycerol, and TG levels upon fasting at 5°C for 6 hr in iBAKO mice (B) (n = 5--8) and for 2 hr in AAKO mice (D) (n = 7).Analyses were performed in female iBAKO and ATGL^flox/flox^ mice aged 40 weeks and 8 weeks upon tamoxifen administration and AAKO mice of mixed sex aged 10--16 weeks. Data are presented as means ± SD. Statistical significance was evaluated by unpaired two-tailed Student's t test. ^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Second, we analyzed AAKO mice ([Table 1](#tbl1){ref-type="table"}; [@bib36]), which we generated by breeding ATGL^flox/flox^ control with adiponectin-Cre mice ([@bib12]), leading to *Atgl* gene deletion in both adipose tissue depots, BAT and WAT. Similar to AKO mice ([@bib18]), an overnight fast for 12 hr at 22°C--23°C decreased body temperature of AAKO mice to ≤32°C, but mice regained normal body temperature upon refeeding for 1 hr ([Figure S3](#mmc1){ref-type="supplementary-material"}B). Food deprivation during cold exposure at 5°C caused hypothermia in AAKO mice already within 90 min ([Figure 3](#fig3){ref-type="fig"}C), confirming previous results ([@bib2]). Hypothermia in cold-exposed fasted AAKO mice was associated with depletion of circulating energy substrates including blood glucose, plasma FA, glycerol, and TG concentrations ([Figure 3](#fig3){ref-type="fig"}D). In contrast, cold-exposed *ad libitum*-fed AAKO mice maintained normal body temperature for at least 6 hr ([Figure S3](#mmc1){ref-type="supplementary-material"}C). Thus, the supply of FAs for energy combustion and cold-induced NST critically depends on ATGL in WAT, but not BAT.

Impaired Heart Function Due to Cardiac ATGL Deficiency Causes Hypothermia {#sec2.4}
-------------------------------------------------------------------------

Global AKO mice, but not iBAKO or AAKO, exhibit impaired cold-induced NST in the *ad libitum*-fed state. These data suggest that ATGL-mediated lipolysis in tissues other than adipose tissues contributes to cold intolerance in AKO mice. We have previously shown that AKO mice exhibit a progressive dilated cardiomyopathy leading to premature death ([@bib18], [@bib19]). Initial evidence for a role of the failing heart in the pathogenesis of cold intolerance was obtained when *ad libitum*-fed AKO mice of different ages and stages of heart disease were acutely transferred from 22°C to 5°C. While 6-week-old AKO mice were able to maintain their body temperature at euthermia of ≥35°C for at least 8 hr, 10-week-old AKO mice became hypothermic (body temperature ≤30°C) as soon as 2 hr after acute cold exposure ([Figure 4](#fig4){ref-type="fig"}A). Evaluation of cardiac function by magnetic resonance imaging (MRI) revealed a shift from a compensated increase in left ventricular (LV) mass with normal ejection fraction in 6-week-old AKO mice to a decompensated cardiomyopathy characterized by a further increase in LV mass associated with severely impaired ejection fraction in 10-week-old AKO mice ([Figures 4](#fig4){ref-type="fig"}B and 4C). These data suggest that impaired cardiac function by the age of 10 weeks underlies cold intolerance of AKO mice.Figure 4Impaired Heart Function Due to Cardiac ATGL Deficiency Causes Hypothermia(A and D) Kaplan-Meier plots depicting mice maintaining euthermia (body temperature ≥35°C) during acute cold exposure at 5°C at indicated time points from AKO (A) and iHAKO mice (D).(B, E, and H) Left ventricular (LV) mass from AKO (B), iHAKO (E), and AKO/cTg mice (H).(C, F, and I) Ejection fraction from AKO (C), iHAKO (F), and AKO/cTg mice (I).(G) Body temperature of male AKO/cTg mice during acute cold at 5°C for 3--6 hr (n ≥ 8).Male AKO mice were analyzed at the age of 6 and 10 weeks (n ≥ 6). iHAKO mice of mixed sex were studied at the age of 12 months and 6 and 10 weeks upon tamoxifen administration (postTAM) (n ≥ 6). Male AKO/cTg mice aged 5--6 months were used to study LV mass and ejection fraction (n = 5). Data are presented as means ± SD, except for Kaplan-Meier plot showing median. Statistical significance was evaluated by Gehan-Breslow-Wilcoxon test for Kaplan-Meier plots or two-way ANOVA and Bonferroni post hoc tests. ^∗∗^p \< 0.01 and ^∗∗∗^p \< 0.001 versus control and ^\#\#\#^p \< 0.001 versus 6-week-old respective groups. See also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.

To test whether cardiac ATGL deficiency affected heart performance, we measured heart rate (HR) by telemetry and determined the low-to-high frequency (LF/HF) ratio of HR variability as measures for cardiac output and autonomic activity, respectively. At baseline at 22°C--23°C, AKO mice had higher HR and sympathetic activation than WT mice ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Upon acute cold exposure at 5°C and compared to baseline, WT and AKO mice increased HR ([Figure S4](#mmc1){ref-type="supplementary-material"}C). However, AKO mice exhibited lower HR that progressively decreased with the reduction in body temperature. Changes in body temperature may affect HR and vice versa. Thus, we applied statistical tests using ANCOVA and corrected our data upon cold exposure (1) for body temperature or (2) for HR. At a hypothetical body temperature of 34°C, AKO mice had still lower and unstable HR than WT mice ([Figure S4](#mmc1){ref-type="supplementary-material"}D). Correcting body temperature for an HR of 689 bpm, there were no differences in estimated body temperature between genotypes ([Figure S4](#mmc1){ref-type="supplementary-material"}E). Together, these findings imply an impaired cardiac reserve as a cause for cold intolerance in AKO mice.

To substantiate the evidence that cardiac dysfunction causes cold intolerance in AKO mice, we used two additional mouse models. First, we studied mice lacking ATGL exclusively in the heart ([Table 1](#tbl1){ref-type="table"}). We used tamoxifen-inducible heart-specific ATGL knockout (iHAKO) mice ([@bib23]) at different times upon gene deletion and performed acute cold studies. Up to 6 weeks upon tamoxifen administration (postTAM), iHAKO mice maintained normal body temperature upon 8 hr cold exposure at 5°C ([Figure 4](#fig4){ref-type="fig"}D). This ability to cope with cold diminished with prolonged *Atgl* gene deletion. Ten weeks postTAM, iHAKO mice became severely hypothermic as early as 1 hr after acute cold exposure. As expected, cold intolerance was not observed in Cre^ER+^ control mice (data not shown). Both treatment groups of iHAKO mice showed increased LV mass, but again, only mice with 10 weeks of tamoxifen-induced *Atgl* gene deletion had a decreased ejection fraction ([Figures 4](#fig4){ref-type="fig"}E and 4F).

Second, we performed a reverse experiment and "rescued" the lethal heart phenotype of AKO mice by re-introducing ATGL expression exclusively in the heart of AKO mice using a cardiac-specific α-MHC-ATGL transgene (AKO/cTg; [Table 1](#tbl1){ref-type="table"}). AKO/cTg mice express ATGL in cardiomyocytes, but lack the enzyme in all other tissues. AKO/cTg mice have a normal heart phenotype and life expectancy, but otherwise phenocopy AKO mice ([@bib19], [@bib39]). Increased BAT weight and morphology, decreased expression of classical BAT marker genes, normal UCP-1 protein abundance in isolated mitochondria, increased total DNA content in whole BAT depots, unchanged total protein content in isolated BAT mitochondria, reduced mtDNA content, decreased expression of PPAR-α target genes, elevated inflammation markers, and mitochondrial morphology were essentially identical in BAT of AKO/cTg and AKO mice ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5I, compared to [Figures 1](#fig1){ref-type="fig"}C--1K, [S1](#mmc1){ref-type="supplementary-material"}A, and S1B). Respiration capacity of BAT homogenates from AKO/cTg and age-matched WT mice expressing the cardiac-specific ATGL transgene (WT/cTg) was similar under all conditions except for a small increase of complex-II-mediated respiration ([Figure S5](#mmc1){ref-type="supplementary-material"}J) and resembled the respiration capacity of AKO mice ([Figure 1](#fig1){ref-type="fig"}L). In contrast to AKO mice, however, 12- to 16-week-old *ad libitum*-fed AKO/cTg mice maintained euthermia upon acute cold exposure at 5°C for 3--6 hr ([Figure 4](#fig4){ref-type="fig"}G). Similar to AAKO mice, AKO/cTg mice demonstrated cold intolerance during fasting at 5°C for 80 min ([Figure S5](#mmc1){ref-type="supplementary-material"}K, compared to [Figure 3](#fig3){ref-type="fig"}C). MRI confirmed that LV mass and ejection fraction were similar in AKO/cTg and WT/cTg mice ([Figures 4](#fig4){ref-type="fig"}H and 4I). These data (1) demonstrate that cardiac dysfunction due to the loss of ATGL in the heart causes hypothermia upon acute cold exposure and (2) corroborate evidence that defective BAT lipolysis can be compensated by circulating substrate delivery when cardiac function is normal.

Because substrate deficiency in response to fasting induced pronounced hypothermia in mice lacking ATGL in WAT (AKO, AAKO, and AKO/cTg), we asked whether hypothermia in 10-week-old *ad libitum*-fed iHAKO mice was due to energy deficiency. Ten weeks postTAM treatment, iHAKO mice had higher blood glucose (+22%), plasma FA (+60%), glycerol (+60%), and TG (+58%) levels, while plasma parameters were similar between groups upon 6 weeks postTAM ([Table S1](#mmc1){ref-type="supplementary-material"}). Increased plasma concentrations of FAs and glycerol were explained by increased *in vitro* TG hydrolase activities in epiWAT of iHAKO mice (data not shown), indicating an increased lipolytic flux. Thus, despite effective mobilization of endogenous energy depots and increased concentrations of circulating energy substrates, iHAKO mice were unable to maintain euthermia (body temperature for ATGL^flox/flox^ control = 37.3°C ± 0.9°C and iHAKO = 26.8°C ± 2.4°C, p \< 0.001), suggesting that the cardiac defect rather than restricted substrate availability causes cold intolerance in iHAKO mice.

ATGL-Deficient Mice Survive upon Cold Acclimation and Exhibit Normal Brown Adipocyte Recruitment {#sec2.5}
------------------------------------------------------------------------------------------------

The contribution of BAT to thermogenesis during acute cold depends on the thermal history of mice ([@bib8]). While mice kept at thermoneutrality (28°C--30°C) have little BAT and react to acute cold exposure predominantly by shivering, mice kept at room temperature (22°C--23°C) have more BAT and respond to acute cold exposure by both BAT activation (NST) and shivering. Prolonged cold exposure (cold acclimation) provokes the recruitment of new brown adipocytes and the biogenesis of mitochondria to cope with chronically increased thermogenesis by the uncoupling process in BAT ([@bib11]). This acclimation process requires several weeks (adaptive NST). To test whether ATGL-deficient mice can cope with cold acclimation for 3 weeks at 5°C, we used AKO/cTg mice lacking ATGL in all cells of the body except cardiomyocytes and measured core body temperature (CBT) using implanted telemetry devices and analyzed brown adipocyte recruitment.

AKO/cTg mice tolerated cold well during cold acclimation ([Figure 5](#fig5){ref-type="fig"}A). Over a time course of 3 weeks, the mean CBT was higher in AKO/cTg (+1.0°C and +0.4°C during light and dark phase) than in WT/cTg mice ([Figure 5](#fig5){ref-type="fig"}B). Similar to AKO/cTg mice, AAKO and iBAKO mice maintained body temperature during cold acclimation at 5°C (data not shown), consistent with the assumption that BAT-ATGL is not required for NST. Similar to our observations in mice during acute cold exposure ([Figure S5](#mmc1){ref-type="supplementary-material"}C), analyses of relative gene expression revealed decreased levels of classical brown fat genes upon cold acclimation ([Figure S6](#mmc1){ref-type="supplementary-material"}). A physiological relevant measure for thermogenic capacity is the amount of UCP-1 protein per animal ([@bib7]). As expected, UCP-1 protein expression per milligram protein of BAT homogenate increased in both genotypes upon cold acclimation compared to normal housing temperatures, but was relatively lower in AKO/cTg mice when normalized to GAPDH expression ([Figure 5](#fig5){ref-type="fig"}C). Total protein content in whole BAT depots also increased upon cold acclimation in both genotypes and was higher in AKO/cTg than in WT/cTg mice due to hyperplasia ([Figure 5](#fig5){ref-type="fig"}D). Accordingly, a calculation of total UCP-1 protein amount in BAT depots revealed no difference between AKO/cTg and WT/cTg mice ([Figure 5](#fig5){ref-type="fig"}E). Together, these results are consistent with normal recruitment of brown adipocytes in AKO/cTg mice.Figure 5ATGL-Deficient Mice Survive upon Cold Acclimation and Exhibit Normal Brown Adipocyte Recruitment(A and B) Time course (A) and mean (B) core body temperature (CBT) of *ad libitum*-fed AKO/cTg mice during cold acclimation at 5°C for 3 weeks using implantable telemetry transmitters (n = 5).(C) UCP-1 immunoblot of BAT homogenates.(D) Total protein content from whole BAT depots (n = 3--5).(E) Calculated total UCP-1 protein amount per BAT of mice housed at 22°C (n = 3) or 5°C for 3 weeks (n = 5).Analyses were performed in *ad libitum*-fed male AKO/cTg mice aged 10--12 weeks. Data are presented as means ± SD. Statistical significance was evaluated by unpaired two-tailed Student's t test. ^∗^p \< 0.05 and ^∗∗∗^p \< 0.001. See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

Adaptive NST Is Intact in ATGL-Deficient BAT {#sec2.6}
--------------------------------------------

To establish a potential role of ATGL in adaptive NST, we analyzed the metabolic response to the β~3~-receptor agonist CL 316,243 (CL) and measured metabolic rates (VO~2~) using indirect calorimetry as well as plasma FA concentrations. We used the iBAKO and AAKO mouse models to differentiate between BAT- and WAT-specific effects of ATGL deficiency on NST *in vivo*. Moreover, we performed the experiments in two separate cohorts of mice upon prior acclimation for 3 weeks to either thermoneutrality or cold. BAT should be "inactive" at thermoneutrality, but maximally "active" upon cold acclimation. Thus, the difference in metabolic rates between thermoneutrality and cold acclimation represents BAT-NST mediated via UCP-1 ([@bib17], [@bib50]).

BAT gross morphology of cold-acclimatized iBAKO and AAKO mice ([Figures S7](#mmc1){ref-type="supplementary-material"}A and S7C) was similar as observed during normal housing temperatures at 22°C--23°C ([Figure 2](#fig2){ref-type="fig"}D). Histological analyses revealed morphological changes in both knockout models with many multilocular lipid droplets upon cold acclimation compared to unilocular lipid droplets during normal housing temperatures ([Figures S7](#mmc1){ref-type="supplementary-material"}B and S7D, compared to [Figure 2](#fig2){ref-type="fig"}E). Glycerol kinase (GyK), a key enzyme in re-esterification and replenishment of the TG pool, was upregulated in both knockout models ([Figures S7](#mmc1){ref-type="supplementary-material"}F and S7E). The underlying mechanism for this upregulation is currently unclear.

CL treatment of iBAKO and ATGL^flox/flox^ control mice kept at thermoneutrality resulted in an indistinguishable response with regard to metabolic rates, plasma FA concentrations, and body temperature ([Figures 6](#fig6){ref-type="fig"}A--6D). In contrast, AAKO mice exhibited a severely impaired β~3~-adrenergic response to CL at thermoneutrality with blunted metabolic rates, decreased plasma FA concentrations, and decreased body temperature. Upon cold acclimation, metabolic rates increased in mice of all genotypes. Yet while iBAKO mice behaved similarly to ATGL^flox/flox^ control mice in response to CL, AAKO exhibited a considerably decreased response ([Figure 6](#fig6){ref-type="fig"}E--6H). Interestingly, and similar to AKO/cTg upon cold acclimation ([Figures 5](#fig5){ref-type="fig"}A and 5B), cold-acclimatized iBAKO mice exhibited moderately higher body temperature than ATGL^flox/flox^ control mice upon 60 min of CL administration ([Figure 6](#fig6){ref-type="fig"}H). Although the reason why mice lacking ATGL in BAT "overheat" remains elusive, it is evident that iBAKO mice respond normally to β~3~-adrenergic stimulation in the absence of BAT-ATGL, arguing for functional WAT lipolysis and intact NST. In contrast, the absence of ATGL-mediated lipolysis in WAT of AAKO mice leads to insufficient substrate supply and a concomitant decrease in metabolic rates and body temperature in response to CL. This inadequate response was observed in mice acclimatized to thermoneutrality and cold at 5°C for 3 weeks.Figure 6Adaptive NST Is Intact in ATGL-Deficient BAT(A--D) Studies in mice acclimatized to thermoneutrality (28°C--30°C).(E--H) Studies in mice acclimatized to cold (5°C).(A and E) Time course of metabolic rates (VO~2~) during basal and upon CL administration upon acclimation to thermoneutrality (A) and to cold (E) (n = 5--9).(B and F) Mean metabolic rates during basal and upon CL administration upon acclimation to thermoneutrality (B) and to cold (F) (n = 5--9).(C and G) Plasma FA levels upon 15 min of CL injection upon acclimation to thermoneutrality (C) and to cold (G) (n = 5--9).(D and H) Body temperature upon 60 min of CL injection upon acclimation to thermoneutrality (D) and to cold (H) (n = 4--6).For analyses upon thermoneutrality, male iBAKO, AAKO, and ATGL^flox/flox^ control mice aged 25--30 weeks were acclimatized for 3 weeks to thermoneutrality at 28°C--30°C (A--D). For analyses upon cold acclimation, male iBAKO, AAKO, and ATGL^flox/flox^ control mice aged 8--12 weeks were acclimatized to cold at 5°C for 3 weeks (E--H). For iBAKO mice, *Atgl* gene deletion was induced 1 week prior to acclimation to thermoneutrality or cold. During cold acclimation, iBAKO and ATGL^flox/flox^ control mice received tamoxifen twice per week to maintain *Atgl* gene deletion. Analyses in iBAKO mice were performed 4 weeks upon tamoxifen administration. Independent of prior acclimation temperatures, metabolic rates (VO~2~) were analyzed at 28°C--30°C in pentobarbital-anesthetized mice using indirect calorimetry (Phenomaster, TSE). Data are presented as means ± SD, except for (A) and (E) showing means. Statistical significance was evaluated by unpaired two-tailed Student's t test or two-way ANOVA and Bonferroni post hoc tests. ^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001 versus control and ^§^p \< 0.05 and ^§§§^p \< 0.001 versus basal. See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

Consistent with defective lipolysis in WAT, cold-acclimatized AKO/cTg and AAKO mice exhibited lower plasma FA concentrations and consumed more food during the light period than cold-acclimatized control or iBAKO mice that are able to mobilize FAs via WAT lipolysis ([Table S2](#mmc1){ref-type="supplementary-material"}). The ability of iBAKO to mobilize FAs from WAT led to moderately smaller epiWAT depots upon cold acclimation, while AKO/cTg and AAKO mice retained increased WAT depots ([Table S2](#mmc1){ref-type="supplementary-material"}).

Impaired or less active BAT may be compensated by alternative mechanisms of heat production like browning of ingWAT. To test whether this occurs upon loss of ATGL, we used iBAKO and AAKO mice and acclimatized them to cold at 5°C for 3 weeks. Marked UCP-1 protein levels were present in ingWAT of mutant and control mice ([Figures S7](#mmc1){ref-type="supplementary-material"}G and S7H). However, we observed normal or decreased UCP-1 protein levels in iBAKO and AAKO ingWAT, respectively, compared to ingWAT of ATGL^flox/flox^ control mice. This suggested that the loss of BAT-ATGL does not cause increased WAT browning.

Discussion {#sec3}
==========

For more than a decade, the lipolytic hydrolysis of TGs in brown adipocytes has been considered essential for cold-induced NST. In particular, the indispensable role of ATGL in this process was emphasized based on both *in vivo* findings and cell culture experiments. Key observations in this context included the severe cold intolerance of AKO and AAKO mice ([@bib2], [@bib18]). Additional mechanistic studies with brown adipocyte cell lines or isolated brown adipocytes assigned a crucial role to ATGL-mediated lipolysis for the provision of FAs for UCP-1 activation ([@bib24]), oxidation and generation of reducing equivalents, and PPAR-α signaling ([@bib29]). Nevertheless, direct proof for an indispensable role for ATGL action in BAT-mediated thermogenesis is missing.

In the current study, we used five different mouse models to elucidate the significance of tissue-specific ATGL expression in BAT, WAT, and cardiac muscle for NST upon acute and chronic cold exposure. Contradicting the current view, we found that ATGL activity in BAT is not required for cold-induced NST. Our conclusion is based on three fundamental findings. (1) iBAKO, AAKO, and "heart-rescued" AKO/cTg mice, all of which lack ATGL in brown adipocytes, maintained normal body temperature during acute cold exposure and cold acclimation in the *ad libitum*-fed state. (2) iBAKO mice responded normally to β~3~-adrenergic stimulation with regard to metabolic rates, plasma FA levels, and body temperature at thermoneutrality and cold acclimation. (3) ATGL-deficient BAT expressed normal amounts of UCP-1 protein per BAT depot and compensatory mechanisms like browning of ingWAT were not observed. Together, these findings strongly argue for an intact adaptive NST in mice lacking ATGL in BAT.

This raises the question of the origin of FAs---independent of ATGL---for UCP-1 activation ([@bib32]), oxidation ([@bib7]), and PPAR-α regulation ([@bib2], [@bib3]) in BAT. In principle, four sources exist to supply FAs. (1) Endogenous FAs are generated by intracellular lipolytic pathways in BAT. In the absence of ATGL, alternative neutral lipases such as HSL or lipophagy ([@bib27]) may fulfill this task and detectable remnant lipase activities in ATGL-deficient BAT argue for the presence of alternative TG hydrolases in BAT. (2) Exogenous FAs are delivered via the circulation and derive from the diet (during feeding) or from WAT lipolysis (during fasting). (3) Exogenous FAs can be additionally delivered by circulating lipoproteins such as intestinal chylomicrons or liver-derived VLDL. The release of FAs from lipoprotein-associated TGs requires either the activity of lipoprotein lipase in the capillary lumen or whole lipoprotein particle uptake into BAT and subsequent lysosomal TG hydrolysis ([@bib4], [@bib53]). (4) Although more unlikely, FAs may originate from *de novo* synthesis.

Our data highlight the crucial importance of these alternative pathways in NST. During fasting, ATGL-catalyzed TG hydrolysis in WAT is indispensable for NST. In iBAKO mice, lacking ATGL exclusively in BAT, the β~3~-adrenergic response to CL stimulation led to normal increases in metabolic rates, plasma FA concentrations (due to intact WAT lipolysis), and body temperature. This response was severely impaired in AAKO mice lacking ATGL in BAT and WAT. Consistent with a strict dependence on ATGL-mediated lipolysis in WAT during fasting, all mouse lines lacking ATGL in WAT (AAKO and AKO/cTg) were highly sensitive to food restriction during cold exposure. In fact, even at room temperature (22°C--23°C), fasting caused a pronounced hypothermia. In the cold, hypothermia was aggravated and lethal upon food deprivation, but reversible upon refeeding. These observations not only show that functional NST depends on WAT lipolysis during fasting, but also emphasize the metabolic flexibility of BAT. We assume that during feeding, chow-derived glucose, circulating unesterified FAs, and/or TG-rich lipoprotein-associated FAs are sufficient as energy substrates for thermogenesis in mice lacking ATGL in WAT and BAT.

Finally, our data emphasize the importance of a functional cardiovascular and hemodynamic system to meet the increased metabolic demand during cold. Mice with impaired heart function ("old" AKO and iHAKO mice) were unable to maintain their body temperature during acute cold while mice with normal heart function ("young" AKO and iHAKO as well as AKO/cTg mice) tolerated cold well. Heart failure in AKO mice was characterized by maladaptive hypertrophy and low ejection fraction. Our data also suggest that AKO mice exhibit tachycardia and autonomic imbalance (sympathetic hyperactivation) under normal conditions. Upon cold stress, AKO mice were incapable of adequately increasing HR and thus cardiac output, which may cause impaired blood flow and substrate supply for thermogenesis. Our statistical model reinforces the hypothesis that impaired cardiac reserve in AKO mice is responsible for cold intolerance. Early studies in BAT research already showed that cold not only stimulates NST, but also increases cardiac output and blood flow ([@bib15], [@bib22]). Similarly, cold intolerance was also shown in other models of impaired heart function ([@bib16], [@bib26], [@bib52]). The cold intolerance in AKO and iHAKO was independent of the presence or absence of ATGL in BAT and/or WAT.

In summary, using highly informative mutant mouse models, we delineate the tissue-specific role of ATGL-mediated lipolysis in NST under energy-sufficient and energy-deprived conditions. Our study demonstrates that ATGL in neither BAT nor WAT is essential for NST in the presence of sufficient dietary (mostly carbohydrate) substrate supply. In the absence of food, ATGL-mediated lipolysis in WAT becomes an indispensable process to provide FAs as fuel substrate. These results imply that both glucose and FAs are utilized as fuel for coping with cold, arguing for a high metabolic flexibility of BAT depending on the nutritional status. Finally, our data reinforce the importance of an intact cardiovascular system to manage cold stress.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
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REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**ATGLCell SignalingCat\#2138; RRID: [AB_2167955](nif-antibody:AB_2167955){#intref0010}UCP-1AbcamCat\#ab10983; RRID: [AB_2241462](nif-antibody:AB_2241462){#intref0015}Glycerol kinase (GyK)AbcamCat\#ab126599; RRID: [AB_11129767](nif-antibody:AB_11129767){#intref0020}GAPDHCell SignalingCat\#2118; RRID: [AB_561053](nif-antibody:AB_561053){#intref0025}Ndufs1AbcamCat\#ab157221Rabbit-HRPCell SignalingCat\#7074; RRID: [AB_2099233](nif-antibody:AB_2099233){#intref0030}**Chemicals, Peptides, and Recombinant Proteins**CL 316,243SigmaCat\#C5976LeupeptinRothCat\#CN33.3AntipainRothCat\#2933.2PepstatinRothCat\#2936.2PVDF membrane, 0.45 μmRothCat\#T830.1Protein Assay DyeBio-RadCat\#500-0006BCA Protein AssayPierceCat\#23225Clarity Western ECL SubstrateBio-RadCat\#170-5061TrioleinSigma-AldrichCat\#T7140Triolein, \[9,10-^3^H(N)\]Perkin ElmerCat\#NET431LPhosphatidyl-CholineSigma-AldrichCat\#P3556Phosphatidyl-InositiolSigma-AldrichCat\#P0639BSA, essentially fatty acid free, 96%Sigma-AldrichCat\#A6003Rotiszint eco plus (scintillation cocktail)RothCat\#0016.3Collagenase Type CLS IIWorthingtonCat\#LS004177Dispase IISigma-AldrichCat\#04942078001DNeasy Blood & Tissue KitQIAGENCat\#69504TrizolInvitrogen, Thermo Fisher ScientificCat\#15596-018Dnase IInvitrogen, Thermo Fisher ScientificCat\#18068-015High-Capacity cDNA Reverse Transcription KitApplied Biosystems, Thermo Fisher ScientificCat\#4374966Maxima SYBR GreenFermentas, Thermo Fisher ScientificCat\#K0223Pyruvate, sodium saltSigma-AldrichCat\#P2256Glycerol-3-phosphate, bis(cyclohexylammonium) saltSigma-AldrichCat\#G7886RotenoneSigma-AldrichCat\#R8875Guanosine 5′-diphosphate, disodium saltSigma-AldrichCat\#51060Atglistatin (ATGLi)[@bib28]N/AHSL inhibitor (HSLi)Novo Nordisk, DK; [@bib40]N/A**Critical Commercial Assays**NEFA-HR(2) R1 SetWako ChemicalsCat\#434-91795NEFA-HR(2) R2 SetWako ChemicalsCat\#436-91995Infinity Triglyceride ReagentThermo Fisher ScientificCat\#TR22421Free gylcerol reagentSigma-AldrichCat\#F6428**Experimental Models: Organisms/Strains**Mouse: AKO: ATGL^−/−^; B6;129P2-Pnpla2tm1Rze/J([@bib18]); The Jackson LaboratoryCat\#019003Mouse: AKO/cTg: ATGL^−/−^/α-MHC-ATGL transgene^+/−^([@bib19], [@bib39])N/AMouse: ATGL^flox/flox^: B6N.129S-Pnpla2tm1Eek/J([@bib43]); The Jackson LaboratoryCat\#024278Mouse: UCP1-Cre^ER^([@bib34])N/AMouse: Adiponectin-Cre: B6; FVB-Tg(Adipoq-cre)1Evdr/J([@bib12]); The Jackson LaboratoryCat\#010803Mouse: α-MHC-MerCreMer: B6.FVB(129)-A1cfTg(Myh6-cre/Esr1^∗^)1Jmk/JThe Jackson LaboratoryCat\#005657Mouse: iBAKO: ATGL^flox/flox^/ UCP1-Cre^ER+/−^This paperN/AMouse: AAKO: ATGL^flox/flox^/ Adiponectin-Cre^+/−^([@bib36]); this paperN/AMouse: iHAKO: ATGL^flox/flox^/ α-MHC-MerCreMer^+/−^([@bib23]); this paperN/AMouse: UKO: UCP1^−/−^; B6.129-Ucp1tm1Kz/JThe Jackson LaboratoryCat\#003124**Oligonucleotides**A full list of sequences is listed in [Table S3](#mmc1){ref-type="supplementary-material"}.This paperN/A**Software and Algorithms**Image Lab software (version 5.2.1)Bio-Rad<http://www.bio-rad.com/en-us/product/image-lab-software>PhenoMaster softwareTSEN/ADataquest A.R.T. software (version 4.31)DSIN/ADatLab software (version 5.1.1.91)OROBOROS InstrumentsN/AMATLABMathWorksN/Aitk-SNAP (version 3.2.0)([@bib54])<http://www.itksnap.org/pmwiki/pmwiki.php>GraphPad Prism 6GraphPad SoftwareN/ASPSS Statistics 24IBMN/A**Other**R/M-H ExtrudateSsniffCat\#V1126-037
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Rudolf Zechner (<rudolf.zechner@uni-graz.at>).

Experimental Model and Subject Details {#sec4.3}
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### Animal Models {#sec4.3.1}

#### General animal study details {#sec4.3.1.1}

All animal protocols were approved by the Austrian Federal Ministry for Science, Research, and Economy (protocol numbers BMWF-66.007/0017/-II/3b/2013 and BMWFW-66.007/0006/-WF/V/3b/2014) and the ethics committee of the University of Graz, and were conducted in compliance with the council of Europe Convention (ETS 123).

Mice were bred and maintained under specific pathogen free conditions. Cages and water were autoclaved, and regular chow diet (R/M-H Extrudate, V1126-037, Ssniff Spezialdiäten GmbH, Soest, Germany) was irridated. Cages were supplemented with nesting material and gnawing sticks, and were changed once weekly. Health status of mice was monitored according to FELASA (Federation of European Laboratory Animal Science Associations) guidelines 3 times per year using the dirty bedding sentinel program. Regular housing temperatures were maintained between 22°C--23°C (71.6°F--73.4°F) with a 14 hr light -- 10 hr dark cycle. Mice were maintained in groups with 2--4 mice per cage and had *ad libitum* access to water and regular chow diet. After animal protocols were completed, mice were anesthetized using isoflurane and blood was collected via the retro-orbital sinus. Mice were euthanized by cervical dislocation; tissues were dissected and immediately processed or flash-frozen in liquid N~2~. Plasma and tissue samples were stored at −80°C until further analyses.

For all studies, age- and sex-matched littermates were used as controls. Genotype, sex, age, and number of mice are indicated for each experiment in the appropriate figure legends. Mice were allocated to experimental groups according to genotype and sex. Immune status of mice was not compromised due to the various genetic deletions. Mice were treatment naive at the time of the study -- except for inducible mutant mice receiving tamoxifen treatment (please see below for iBAKO and iHAKO mice).

#### Global ATGL knockout mice {#sec4.3.1.2}

Global ATGL knockout (AKO) mice were generated by breeding heterozygous AKO mice ([@bib18], [@bib19]). AKO mice were backcrossed into C57BL/6J for \> 10 generations. Independent of sex, AKO mice fed a regular chow diet are moderately obese with a ∼2-fold increase in total body fat mass and develop a progressive cardiomyopathy leading to premature death at the age of ≥ 12 weeks for males and ≥ 16 weeks for females ([@bib18]). Cold experiments were performed in 6- to 10-week-old AKO mice.

#### Inducible BAT-specific ATGL knockout mice {#sec4.3.1.3}

ATGL^flox/flox^ control mice ([@bib43]; The Jackson Laboratory; JAX stock number 024278; backcrossed into C57BL/6J for two generations) were bred with UCP1-Cre^ER^ ([@bib34]; genetic background: C57BL/6N) mice to obtain inducible BAT-specific ATGL knockout (iBAKO) mice. *Atgl* gene deletion was induced by oral gavage of 2 mg tamoxifen (Sigma-Aldrich, St. Louis, MO) solubilized in peanut oil (Sigma) per mouse for 5 consecutive days. Both iBAKO and ATGL^flox/flox^ littermates obtained tamoxifen treatment. As indicated in the figure legends, studies were performed 4--8 weeks after the first tamoxifen administration.

Prior to acclimation of iBAKO and ATGL^flox/flox^ control mice for 3 weeks to thermoneutrality at 28°C--30°C or cold at 5°C, *Atgl* gene deletion was induced as described above. Thereafter, mice were allowed to acclimatize to the new ambient temperature. To maintain *Atgl* gene deletion during cold acclimation, an extended treatment strategy was applied to iBAKO and ATGL^flox/flox^ littermates with 2 mg tamoxifen per mouse being orally administered twice per week.

#### Adipocyte-specific ATGL knockout mice {#sec4.3.1.4}

ATGL^flox/flox^ mice were crossbred with Adiponectin-Cre mice ([@bib12]; The Jackson Laboratory; JAX stock number 010803; genetic background: C57BL/6J) to obtain adipocyte-specific ATGL knockout (AAKO) mice. Body composition of AAKO mice was similar as previously published ([@bib36]). Body weight was unchanged compared to ATGL^flox/flox^ control mice, but fat mass was ∼1.7-fold higher.

#### "Heart-rescued" AKO mice {#sec4.3.1.5}

Mutant AKO mice with a cardiac-specific ATGL transgene overexpression (AKO/cTg mice; "heart-rescued" AKO mice) were generated by breeding heterozygous AKO with heterozygous AKO mice that were also heterozygous for the cardiomyocyte-specific α-MHC-ATGL transgene ([@bib19], [@bib39]). Wild-type (WT) mice overexpressing the α-MHC-ATGL transgene (WT/cTg) were used as controls. AKO/cTg mice were backcrossed into C57BL/6J for \> 10 generations. Independent of sex, AKO/cTg phenocopy AKO mice in regard to body composition, but exhibit no cardiomyopathy and show a life expectancy similar to WT/cTg mice ([@bib19], [@bib39]).

#### Inducible Heart-specific ATGL knockout mice {#sec4.3.1.6}

ATGL^flox/flox^ mice were bred with α-MHC-MerCreMer mice (The Jackson Laboratory, JAX stock number 005657; backcrossed into C57BL/6J for \> 10 generations) to obtain inducible heart-specific ATGL knockout (iHAKO) mice. Deletion of the *Atgl* gene was induced in mice aged ≥ 12 weeks by oral gavage of 50 mg tamoxifen per kg body weight for 5 consecutive days. Both iHAKO and ATGL^flox/flox^ littermates obtained tamoxifen treatment. Experimental protocols were performed in mice 6- or 10-weeks after the first tamoxifen administration (postTAM). Heart-specific *Atgl* gene deletion did not change overall body, but affected heart function ([@bib23]; and results within this study).

#### UCP-1 knockout mice {#sec4.3.1.7}

Heterozygous mice were used to breed UCP-1 knockout (UKO) mice (The Jackson Laboratory; JAX stock number 003124) at standard ambient temperatures at 22°C--23°C.

Method Details {#sec4.4}
--------------

### *In vivo* studies {#sec4.4.1}

#### Studies at cold and thermoneutrality {#sec4.4.1.1}

For acute cold studies, mice were transferred from 22°C--23°C to 5°C for indicated time periods. Acute cold studies were started between 9--10 am. For cold acclimation studies, mice were transferred from 22°C--23°C to 5°C and maintained at 5°C for 3 weeks. For all cold studies, mice were single-housed without nesting material and had free access to food and water unless otherwise stated. For acclimation to thermoneutrality, mice were transferred to a room with controlled ambient temperature at 28°C-- 30°C and a humidity of 35--45% for 3 consecutive weeks.

#### Body temperature {#sec4.4.1.2}

Body temperature was assessed in conscious mice using a rectal probe RET-3 (Physitemp, Clifton, NJ). Core body temperature (CBT) was studied using implantable telemetry devices (TA-F10, Data Sciences International, DSI, St. Paul, MN). For the implantation of telemetry devices, mice were anesthetized with 80 μg ketamine and 8 μg xylazine per g body weight. The abdominal skin region was depilated and disinfected with iodine-containing solution (Betadine). Thereafter, a small vertical skin incision was made in the center of the abdomen, the peritoneal cavity was opened, and a sterile telemetry device was inserted. The peritoneum and the abdominal skin were closed using absorbable sutures and wound clips, respectively. Mice were returned to their home cages and kept on heating plates at 37°C until full consciousness was retrieved. Animals received 0.1 mg enrofloxacin and 2 mg ibuprofen per ml drinking water for 1 week. Together, mice were allowed to recover from surgery for at least 2 weeks. Finally, wound clips were removed before the start of analyses. CBT was continuously assessed at an interval of 2 min for indicated time periods. Data acquisition and analyses were performed using Dataquest A.R.T. software (version 4.31; DSI). CBT is presented as mean over group.

#### Fasting regimen {#sec4.4.1.3}

Overnight fasting studies were performed at 22°C--23°C from 7 pm until 7 am and subsequent refeeding for 1 hr. For fasting experiments at 5°C, *ad libitum*-fed mice were transferred to new cages at 9 am for indicated time periods. Mice were removed from the cold when their body temperature dropped below 28°C.

#### Food intake {#sec4.4.1.4}

During cold acclimation at 5°C for 3 weeks, food intake was determined by manually weighing the food from single cages every day at 9 am and 6 pm representing dark and light periods, respectively.

#### Magnetic resonance imaging {#sec4.4.1.5}

Magnetic resonance imaging (MRI) measurements were performed using a 7T small animal MRI (Bruker BioSpec, Ettlingen, Germany) equipped with a 660 mT/m gradient coil. A 86-mm-diameter transmit coil was used in combination with a 20-mm-diameter surface coil for receive. Mice were anesthetized (1.5--2.0% isoflurane with 98--98.5% O~2~) and scanned in prone position. Body temperature was maintained at 37°C by a water heated animal bed. ECG electrodes were placed on the right front and left back paws, and a balloon pressure sensor was placed on the abdomen for respiratory gating.

Cine MR images were acquired using an ECG-triggered and respiratory-gated gradient echo sequence with the following parameters: pulse repetition time/echo time = 11.5/2.65 ms, α = 15°, 8 averages, an image matrix of 192 × 192 at a FOV of 25 × 25 mm^2^ and a slice thickness of 1 mm. Two slices were acquired per repetition with an inter-slice gap of 1 mm. Whole heart coverage in short axis view was achieved by 4 slice packages interleaved by 1 mm inter-slice shift resulting in 8 image slices without slice gaps covering the heart from apex to base. MRI acquisitions started at the up-slope of the ECG R-wave and 9 cardiac frames were consecutively recorded. Total imaging time was approximately 20 min.

The myocardial wall was manually segmented in all short axis views using itk-SNAP (version 3.2.0) ([@bib54]) to obtain left-ventricular (LV) epicardial and endocardial volumes at the end-diastole and end-systole while papillary muscles were excluded from the lumen. LV mass was calculated from end-diastolic myocardial volume using a tissue density of 1.04 g/cm^3^. Ejection fraction was obtained by the difference of end-diastolic and end-systolic endocardial volume divided by the end-diastolic endocardial volume multiplied by 100%.

#### ECG and heart rate analyses using telemetry {#sec4.4.1.6}

ECG recordings were obtained using radio frequency transmitters (TA10ETA-F20, DSI). ECG telemetry devices were implanted subcutaneously in the back space (lead II configuration) of 7-week-old male AKO mice and age-matched WT littermates (body weight: 21--25 g) under general anesthesia using avertin (0.025 mg per kg body weight). Body temperature was maintained at 37°C by a thermostatically controlled heating pad until recovery from anesthesia. Mice were allowed to recover from the surgery for 6 days and body weight was daily monitored. After convalescence and reaching the age of 8 weeks, telemetry was continuously recorded for 24 hr starting at 6 am in ambulatory, unrestrained mice at an ambient temperature of 22°C--23°C for baseline measurements. Then, mice were exposed to acute cold at 5°C for 4 hr. ECG signals were acquired at a sampling rate of 1 kHz.

Beat-to-beat alterations in the heart rate (HR) were analyzed offline using a custom-made script (MATLAB, MathWorks, Natick, MA) using the periodic variation in R-R intervals. ECG signals were scanned for R-wave detection and calculation of R-R intervals and HR. Given the non-stationary nature of ECG signals in mice, multiple short-term recordings were analyzed ([@bib46]). A total of 6 recordings in 2 hr intervals and each lasting for 180 s during a period of minimal animal movement (telemetry-monitored motor activity) were selected. The selected recordings were examined visually (on the tachogram) and by predefined formulas in the script for the detection of any ectopic beats, which were strictly excluded to avoid confounding effects on the HR variability analysis. All included recordings had less than 5% of the total beat count identified as ectopic.

R-R interval time-series were transformed and studied in the frequency domain using the power spectral density analysis with moderate modifications to adapt the analysis for the fast heart rates of a mouse ([@bib1]). R-R interval values were linearly interpolated to generate an equi-distant time-series at a new sampling frequency of 20 Hz and were then detrended using a sixth-order polynomial fitting. Power spectral density analysis was performed using the Welch method by dividing the signal into 1800-point segments with 50% overlap followed by a fast Fourier transformation on each hanning-windowed segment. Segments were averaged and squared to obtain the frequency components of each time-series. The resulting periodograms had a minimum frequency resolution of 0.0111 Hz. Autospectra were integrated between the cut-offs of low and high frequency (LF and HF, respectively) powers of mouse HR variability, 0.4-1.5 Hz and 1.5-4 Hz, respectively. The LF/HF ratio was calculated as a measure of autonomic activity.

To analyze the effect of the two dependent parameters of body temperature on HR and vice versa, we used analysis of covariance (ANCOVA) ([@bib47]). For details, please see the "[Quantification and Statistical Analysis](#sec4.5){ref-type="sec"}" section.

#### Analyses of non-shivering thermogenesis {#sec4.4.1.7}

To test the non-shivering thermogenic (NST) capacity, metabolic rates upon administration of the β~3~-receptor agonist CL 316,243 (Sigma) were studied using a laboratory animal monitoring system (PhenoMaster, TSE Systems GmbH, Bad Homburg, Germany). Mice were anesthetized with pentobarbital (75 mg per kg body weight, *i*.*p*. injection), which does not inhibit NST ([@bib14], [@bib50]). Basal metabolic rates were monitored for subsequent 30 min until reaching steady-state. Then, CL 316,243 was injected *i*.*p*. using a dosage of 1 mg per kg body weight. The subsequent increase in metabolic rates was monitored for 60--80 min. Prior to the analyses, mice were acclimatized for 3 weeks to thermoneutrality at 28°C--30°C or cold at 5°C (see also "[Studies at cold and thermoneutrality](#sec4.4.1.1){ref-type="sec"}"). Metabolic rates were monitored at thermoneutral temperature (28°C--30°C) independent of prior acclimation temperatures ([@bib50]). Control and knockout mice were analyzed in parallel in an interval of 2 min (1 min per cage). Data were analyzed using PhenoMaster software and are expressed as VO~2~ (ml/h).

### *Ex vivo* studies {#sec4.4.2}

#### BAT fractionation {#sec4.4.2.1}

Fresh BAT depots were collected and freed from WAT. BAT was finely minced into small pieces and digested using Collagenase Type CLS II (1 mg/ml, 332 U/mg; Worthington Biochemical Incorp., Lakewood, NJ) and Dispase II (3.3 mg/ml; 0.9 U/mg; Sigma) dissolved in PBS supplemented with 10 mM CaCl~2~ for 45--60 min at 37°C and 110 rpm. Enzymes were inactivated by the addition of DMEM containing 10% FBS. Then, cell suspensions were filtered through a 100 µm cell strainer. To fractionate different cell types, brown adipocytes were allowed to float (for AKO and iBAKO mice only to avoid undesired bursting of lipid-loaden adipocytes) and adipocytes from AKO and iBAKO were collected. Then, the remaining cell suspensions of all genotypes were spun for 10 min at room temperature and 200 x g. The floating brown adipocytes were collected. To pellet cells from the stroma-vascular fraction (SVF), the remaining cell suspensions were centrifuged for 10 min at room temperature and 1,000 x g. Supernatants were disposed, SVF cells were treated with erythrocyte lysis buffer (154 mM NH~4~Cl, 10 mM KHCO~3~, 0.1 mM EDTA pH: 7.4) for 2 min, and cells were washed with PBS. Fractionation of BAT from control and mutant mice was performed in parallel. DNA from isolated brown adipocytes and SVF was isolated as described below.

#### Analyses of oxygen consumption rates {#sec4.4.2.2}

Fresh BAT depots were collected and freed from WAT. BAT was finely minced into small pieces, homogenized in ice-cold 250 mM sucrose for 2--3 s using Ultra-Turrax Homogenizer. Prior to the analyses, homogenates were freed from connective tissue using a 100 µm cell strainer. Oxygen consumption rates (OCRs) were measured at 37°C by high-resolution respirometry using polarographic oxygen sensors in a two-chamber oxygraph (OROBOROS Instruments, Innsbruck, Austria). An aliquot of 50 µl of BAT homogenate (total volume = 1 mL per half BAT depot) was incubated in a medium containing 125 mM sucrose, 20 mM K-Tes (pH: 7.2), 2 mM MgCl~2~, 1 mM EDTA, 4 mM KH~2~PO~4,~ 3 mM malate, and 0.1% essentially fatty acid (FA)-free BSA. Respiration was analyzed by the following protocol adding substrates sequentially upon reaching steady-state: 5 mM pyruvate (pyr; complex-I), 5 mM glycerol-3-phosphate (G3P; complex-II), 0.5 µM rotenone (R; inhibitor of complex-I), and 2 mM guanosine 5¢-diphosphate (GDP, dissolved in 20 mM K-Tes-buffer pH: 7.2). Substrates and inhibitors were prepared according to Oroboros O2k Protocols ([http://www.bioblast.at/index.php/ MiPNet03.02_Chemicals-Media](http://www.bioblast.at/index.php/%20MiPNet03.02_Chemicals-Media){#interref0010}). Data acquisition and analyses were performed using DatLab software (version 5.1.1.91). Analyses of control and mutant mice were prepared and run in parallel. OCRs in BAT homogenates were calculated for whole BAT depot per mouse and are expressed as nmol per s and total BAT depot.

#### Lipolysis assays {#sec4.4.2.3}

Fresh BAT and epiWAT depots were dissected from *ad libitum*-fed mice and put into DMEM (GIBCO, Invitrogen, Thermo Fisher Scientific, Waltham, MA) supplemented with 2% FA-free BSA. Adipose tissue (AT) depots were cut into small pieces and transferred into DMEM supplemented with 2% FA-free BSA in 96-well plates for 30 min (pre-incubation). To analyze basal lipolysis, AT pieces were transferred into 150 µl fresh media and incubated for further 60 min. Then, AT pieces were transferred into 150 µl DMEM supplemented with 2% FA-free BSA in the presence of 10 µM isoproterenol (ISO) in 96-well plates and pre-incubated for 30 min. To analyze stimulated lipolysis, AT pieces were transferred into 150 µl fresh media containing 10 µM ISO and incubated for another 60 min. To determine basal and stimulated lipolysis, glycerol content was analyzed in the media. Please see "[Blood chemistry](#sec4.4.3.9){ref-type="sec"}" for the analyses of glycerol content. At the end of the experiment, AT pieces were delipidated by CHCl~3~ extraction and solubilized in 0.3 N NaOH/0.1% SDS at 65°C overnight. Protein content was determined using Pierce BCA Protein assay (Pierce, Thermo Fisher Scientific) and BSA as standard. For each mouse, fat depot, and condition, five replicates were ran in parallel. Data are expressed as glycerol per mg tissue protein.

### *In vitro* studies {#sec4.4.3}

#### Histology {#sec4.4.3.1}

BAT was fixed in 4% buffered formaldehyde and embedded in paraffin. Sections were stained with hematoxylin and eosin using standard protocols. Scale bar, 100 µm.

#### Transmission electron microscopy {#sec4.4.3.2}

BAT depots from mice exposed to acute cold at 5°C were collected and small fragments of tissue were fixed in 2.5% glutaraldehyde and 0.5% paraformaldehyde in 0.1 M phosphate buffer, pH: 7.4 for 2 hr. Then, tissues were rinsed in 0.1 M phosphate buffer for 30 min and post-fixed in 2% osmium tetroxide for 60 min. Tissue pieces were rinsed in 0.1 M phosphate buffer for 30 min and dehydrated in 50%, 70%, 90%, and 100% cold acetone for 20 min each. Thereafter, tissues were infiltrated by 2:1, 1:1, and 1:2 mixtures of 100% acetone and agar 100 epoxy resin (Gröpl, Tulln, Austria) and pure agar 100 epoxy resin for 4 hr. The tissues were then placed in agar 100 epoxy resin at room temperature for 8 hr, transferred into embedding molds and polymerized at 60°C for 48 hr. Ultrathin sections of 75 nm were cut with a Reichert Ultracut S Ultramicrotome and stained with lead citrate for 5 min and with uranyl acetate for 15 min. Images were taken using a Zeiss EM 902 transmission electron microscope equipped with a digital camera system. Scale bar, 0.5 µm.

#### Tissue Homogenization {#sec4.4.3.3}

AT depots (BAT, epiWAT, ingWAT) were homogenized in ice-cold solution A (0.25 M sucrose, 1 mM EDTA, 1 mM dithiothreitol, pH: 7.0 supplemented with 20 µg/ml leupeptin, 2 µg/ml antipain, 1 µg/ml pepstatin; Carl Roth GmbH & Co KG, Karlsruhe, Germany) using Ultra-Turrax Homogenizer (IKA, Staufen, Germany). For immunoblotting of proteins in AT, homogenates were centrifuged for 10 min at 4°C and 1,000 x g. An aliquot of the supernatant including the fat cake was then delipidated overnight at -20°C using a 5-fold volume of ice-cold acetone. Proteins were precipitated by centrifugation for 30 min at 4°C and 20,000 x g, and solubilized by sonification in solution A. For *in vitro* TG hydrolase activity assays, homogenates were centrifuged for 30 min at 4°C and 20,000 x g and low-fat tissue infranatants were collected. Protein concentrations were determined using Protein Assay Dye (Bio-Rad Laboratories, Hercules, CA) and BSA as standard.

#### Isolation of BAT mitochondria {#sec4.4.3.4}

Mitochondria from whole BAT depots were isolated from fresh tissues according to [@bib42]. Therefore, BAT depots were cleaned from visible WAT, placed into ice-cold 250 mM sucrose, finely minced, and homogenized using Ultra-Turrax Homogenizer. BAT homogenates were filtered through a 100 µm cell strainer and centrifuged for 10 min at 4°C and 8,500 x g. The resulting supernatant containing floating fat was discarded. Pellets containing nuclei and mitochondria were gently re-suspended in ice-cold 250 mM sucrose using a Potter homogenizer (loose fit) and centrifuged for 10 min at 4°C and 800 x g. The resulting pellets (nuclei) were discarded and the supernatant was again centrifuged for 10 min at 4°C and 8,500 x g. Then, the mitochondrial pellets were washed twice with 100 mM KCl, 20 mM K-Tes (pH: 7.2) were re-pelleted by centrifugation for 10 min at 4°C and 8,500 x g. Mitochondrial protein concentrations were determined using Protein Assay Dye (Bio-Rad) and BSA as standard.

#### Immunoblotting {#sec4.4.3.5}

Unless otherwise stated, protein samples of 10--50 µg were solubilized, denatured in SDS sample buffer, resolved by SDS-PAGE (10%--12.5% Tris-glycine) and transferred onto a polyvinylidene fluoride (PVDF) transfer membrane (Roth) in CAPS buffer (10 mM CAPS, 10% methanol, pH: 11.0). The membrane was blocked with 10% blotting grade milk powder (Roth) in TST (50 mM Tris-HCl, 0.15 M NaCl, 0.1% Tween-20, pH: 7.4). A list of antibodies is indicated in the [Key Resources Table](#sec4.1){ref-type="sec"}.

Protein expression was visualized by enhanced chemiluminescence using Clarity Western ECL Substrate and ChemiDoc Touch Imaging System (both Bio-Rad). Signal intensities were quantified by densitometric analyses using Image Lab software (version 5.2.1; Bio-Rad).

For the quantification of total UCP-1 tissue protein content upon cold acclimation, whole BAT depots were crushed in liquid N~2~ using a mortar and pestle. An aliquot was weighed, homogenized, and protein concentrations were determined using Protein Assay Dye (Bio-Rad) and BSA as standard. Total tissue protein content was calculated accounting for total BAT mass. Similarly, an aliquot of indicated total BAT protein was resolved via SDS-PAGE and UCP-1 signal intensities were determined and normalized to GAPDH. Total UCP-1 protein content was calculated accounting for whole BAT protein content.

#### TG hydrolase activities {#sec4.4.3.6}

Lipolytic activities were assessed as described ([@bib21], [@bib41]). The TG substrate consisted of 165 nmol triolein (Sigma) and \~1 × 10^6^ cpm triolein \[9,10-^3^H(N)\] (NET431L, Perkin Elmer, Waltham, MA) per assay emulsified with 45 µM phosphatidyl-choline/-inositol (3:1, 20 mg/ml, Sigma) in 100 mM K-phosphate buffer (pH: 7.0). Substrates were emulsified by sonication on ice (Virsonic 475, Virtis, Gardiner, NJ). After sonication, substrates were adjusted to 2% FA-free BSA (Sigma). To determine TG hydrolase activities, 100 µl substrate were mixed with 25 µg tissue lysates to obtain a final volume of 200 µl. As blank, 100 µl solution A were incubated under the same conditions as samples. TG hydrolase activities were inhibited using small-molecule inhibitors specific for ATGL (Atglistatin, ATGLi; final concentration: 40 µM, synthesized by R. Breinbauer/TUG, Graz, Austria; [@bib28]) or for HSL (HSLi; final concentration: 10 µM; gift from NovoNordisk, Copenhagen, DK; [@bib40]). The reaction mixture was incubated in a water bath at 37°C for 1 hr. Then, 3.25 mL of methanol/chloroform/heptane (10/9/7, v/v/v) and 1 mL of 0.1 M potassium-carbonate/0.1 M boric acid (pH: 10.5) were added to terminate the reaction. The reaction mixture was intensively vortexed and centrifuged for 10 min at 800 x g. An aliquot of 0.4 mL of the upper aqueous phase was collected in 2 mL Rotiszint eco plus (Roth) and the radioactivity was analyzed using liquid scintillation counting (Rotiszint eco plus, Roth; Tri-Carb 2100TR, Packard Instrument Company, Downers Grove, IL). Corrections for background were accounted using counts obtained for blank incubation. Samples from control and mutant mice were run in parallel and analyzed in duplicates. TG hydrolase activities are expressed as released FA per h and normalized to mg protein.

#### Nucleic acid isolation and quantification {#sec4.4.3.7}

DNA from whole BAT depots or from fractionated BAT cell types was isolated following manufacturer's instructions using DNeasy Tissue Kit (QIAGEN, Hilden, Germany). Total RNA was extracted from snap-frozen tissues using Trizol reagent following manufacturer's instruction (Invitrogen). The quality of RNA was verified by standard agarose gel electrophoresis. DNA and RNA concentrations were analyzed using NanoDrop microvolume spectrophotometer (Thermo Fisher Scientific).

#### Gene expression and mitochondrial DNA content {#sec4.4.3.8}

For relative gene expression analyses, whole BAT RNA was used to prepare BAT cDNA. To avoid DNA contaminations, 2 µg RNA were digested with Dnase I (Invitrogen; 1U/µl) at 25°C for 15 min followed by heat inactivation of the enzyme at 65°C for 10 min. Thereafter, 1 µg RNA was transcribed using random primers and a High-Capacity cDNA Reverse Transcription Kit (both Applied Biosystems, Thermo Fisher Scientific). Independent of tissue RNA or DNA content, 8--40 ng BAT cDNA or whole BAT DNA were used for the PCR reaction using 10 pmol of forward and reverse primers, Maxima SYBR Green (Fermentas, Thermo Fisher Scientific), and StepOnePlus Real-Time PCR System (Thermo Fisher Scientific). Relative gene expression and mitochondrial (mt) DNA content were analyzed using the ΔΔ-Ct method ([@bib25]). Relative gene expression was normalized to TBP or 36B4. Relative mtDNA content was determined as ratio of the copy numbers from the mtDNA encoded gene (MtCO1) to the nuclear DNA encoded gene (Ndufv1). A list of gene-specific primers is available in [Table S3](#mmc1){ref-type="supplementary-material"}.

#### Blood chemistry {#sec4.4.3.9}

Plasma FA (NEFA-HR(2) R1 and R2 Set, Wako Chemicals, Neuss, Germany), TG (Infinity Triglyceride Reagent, Thermo Fisher Scientific), and glycerol (Free glycerol reagent, Sigma) concentrations were quantified using enzymatic colorimetric methods following manufacturer's instructions. Blood glucose levels were monitored using Wellion Calla glucometer (MedTrust, Marz, Austria).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Figures were prepared using GraphPad Prism 6 (GraphPad Software, San Diego, CA). All data are shown as means ± SD, except otherwise stated. In each experiment, *n* defines the number of mice. Statistical significance between two groups was determined by unpaired, two-tailed Student's t test and between more than two groups using two-way analyses of variance (ANOVA) and Bonferroni post hoc tests (SPSS Statistics 24, IBM, Armonk, NY). Statistical significance of Kaplan-Meier plots was analyzed using Gehan-Breslow-Wilcoxon test (GraphPad). A general mixed linear model was used to perform two-way repeated-measurements analysis of covariance (ANCOVA; SPSS Statistics 24) of HR and body temperature, which generated the estimated HR and estimated body temperature values ([@bib47]). Normal distribution of data for HR and body temperature residuals and equality of variances were confirmed by Shapiro-Wilk test and Levene's test, respectively. Apart from this, no statistical method was used to determine whether the data met assumptions of the statistical approach. For HR and ANCOVA analyses, data were excluded from animals whose body temperature did not drop during cold exposure of 4 hr. Apart from this, no exclusion or inclusion criteria had been used for data analyses. Group differences were considered statistically different for ^∗^, p \< 0.05, ^∗∗^, p \< 0.01, and ^∗∗∗^, p \< 0.001. Statistical parameters can be found in the figure legends.
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[^1]: Lead Contact

[^2]: This table gives an overview of mouse models used in this study and indicates ATGL protein expression in respective tissues. BAT, brown adipose tissue; WAT, white adipose tissue; CM, cardiac muscle; (--) indicates that no ATGL protein is expressed; (+) indicates that ATGL protein is expressed.
